0,1,2,3
BioMed Research International,,,3
,Table 1: Primers used in this study.,,
Primer name,Sequence (5’-3’),Purpose,
sRNase L-KO-3-Fwd,CACCTTCATGGAAGCCGCCGTGTA,,
,,sRNase L knockout,
sRNase L-KO-3-Rev,AAACTACACGGCGGCTTCCATGAA,,
sRNase L-KO-4-Fwd,CACCCAGCCGAGCCAACGATAACG,,
,,sRNase L knockout,
sRNase L-KO-4-Rev,AAACCGTTATCGTTGGCTCGGCTG,,
sRNase L-Fwd,ATGGAGACCAAGCGCCATAACAAC,,
,,,sRNase L amplification
sRNase L-Rev,CTAGGTCTGGCCATCACCAGCTC,,
sISG43-Fwd,TGAGGAGCAGAGGAGAAATG,,
,,ISG43 amplification,
sISG43-Rev,GGAGACAGTAGGCAAGTTCC,,
sISG15-Fwd,GCAATGTGCTTCAGGATGG,,
,,ISG15 amplification,
sISG15-Rev,AGGCTTGAGGTCATACTCCC,,
sISG56-Fwd,GGAGTTGGTCATTCAAGACAC,,
,,ISG56 amplification,
sISG56-Rev,CGTAAGGTAATACAGCCAGGC,,
sOAS1-Fwd,ATGCTGACCTCGTCGTCTTC,,
,,OAS1 amplification,
sOAS1-Rev,GGACATCAAACTCCACCTCC,,
sOAS2-Fwd,TCTGGGCACAGTTGAAATG,,
,,OAS2 amplification,
sOAS2-Rev,GATGCTCTGCTCTTTAGCG,,
sMx1-Fwd,TGAACGAAGAAGACGAATGG,,
,,Mx1 amplification,
sMx1-Rev,CGTATGGCTGATTGCCTAC,,
sGAPDH-Fwd,ATCACCATCTTCCAGGAGC,,
,,GAPDH amplification,
sGAPDH-Rev,TTCACGCCCATCACAAAC,,
PRV-Fwd,TGAACATCCTCACCGACTTC,,
,,PRV gD amplification,
PRV-Rev,TAGAACGGCGTCAGGAATC,,
